Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Open
Phase 3
This trial is comparing nemtabrutinib with ibrutinib or acalabrutinib for chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
It is for people who haven’t yet had treatment for CLL or SLL.
You pronounce nemtabrutinib as nem-ta-broo-ti-nib.
Recruitment start: 26 January 2024
Recruitment end: 19 July 2027
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Toby Eyre
Merck Sharp & Dohme Ltd
Last reviewed: 27 Nov 2025
CRUK internal database number: 19841
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
